I write your
Written to pass AHPRA and TGA review and still book patients. Compliance checked line by line, with the evidence report attached.
Amisha Sharma · compliance checked copy · evidence report with every page
Amisha Sharma is a peptide clinic copywriter in Australia and an ISB alumna at Commas & Chaos. She writes compliance checked healthcare copy for Australian practices and agencies. No delivered work of hers has been flagged by a regulator to date. Every page she writes is checked 226 ways before it ships.
"Our BPC-157 protocol repairs injury fast. Order your peptide course online today, delivered to your door."
This advertises a prescription-only compound to the public, which is prohibited. It also promises a therapeutic outcome the prescriber has not decided yet.
"Book a consultation with an Australian registered doctor about recovery and healthy ageing. What happens on the call, what it costs, and how the doctor decides whether any treatment is appropriate for you."
Compliant, clear, and honest about the gate. It also converts better, because a cautious first-time patient wants to know what the appointment involves.
Compliant copy has a reputation for being boring. That is a writing problem, not a compliance one. I fix the writing.
On 10 June 2026 the TGA expanded its priority compliance focus to unapproved peptide products. If your site names a compound, promises a result, or sells a protocol, it is at risk right now. Check in 60 seconds.
Six quick questions. Your results, straight away.
I'm a peptide clinic copywriter. Your website is the core, and it's where most clinics start. Need Google Ads, social, or SEO articles too? I write those as well.
The page that decides if they stay or bounce.
Each consult type, written so it sells the appointment.
Your prescribers and their registration. The trust page.
The questions people are too shy to ask.
For a campaign or a single service.
Ads that pass Google, Meta and the TGA at once.
Captions that survive Meta review and the rules.
The questions patients Google before they book.
What to publish, where, and in what order.
226 checks on your current site. Fixed at $1,500.
One writer for all of it. Quoted flat, upfront.
Advertising a prescription-only medicine to the public is prohibited under the Therapeutic Goods Act. A doctor may lawfully prescribe an unapproved peptide for a specific patient. That is a clinical pathway, not a marketing licence. I write to the current TGA and AHPRA rules every day.
I structure your pages so Google and AI search can understand them. That gives you a real shot at showing up when someone searches for a peptide clinic or a longevity consult.
Copy that reads like a real clinical service, not a supplement shop. It brings in patients who complete a program and come back, instead of one-course buyers who churn and complain.

You are never a ticket number in an agency queue. You brief me, I write, and the person answering your email is the person who wrote your homepage. That is why the quality holds.
Tell me about your clinic and what you need written. Five minutes.
A 30-minute call, then one flat fee. No hourly billing, no lock-in.
Every page written, checked, and handed over ready to publish. Two rounds of edits.

I'm Amisha Sharma, a compliance-first copywriter for regulated Australian brands, peptide clinics included. I am an ISB alumna, agency trained on Australian accounts. No delivered work of mine has been flagged by a regulator to date. Every page runs through my 226-point GhostRank audit before it ships. Peptides are the highest-risk lane in Australian health marketing. I write them accordingly.
Because most of them will write you an unlawful medicine ad without knowing it. Here is the honest comparison.
Ranks you for the compound name, then gets you fined for ranking. They know Google. They have never read section 42DL.
Keeps you legal and hands you copy no one reads. Safe and invisible is still invisible.
Copy that names the peptide. You save a few hundred dollars and expose the clinic to a penalty in the millions.
Fast, generic, no judgement. It will happily write the protocol page the rules prohibit.
Compliant, ranks, quoted by AI, books consults. I do all four. And I personally watch every word, so you always know who is writing: me. Every page passes the 226-point GhostRank check first.
Short version: you can describe the consultation in full detail. You cannot advertise the prescription-only compound behind it. Here is how that plays out on a real clinic site.
Because the sector grew faster than its compliance did. On 10 June 2026 the TGA expanded its priority compliance focus to unapproved peptide products, naming products of concern including BPC-157, GHK-Cu, TB-500, retatrutide and CJC-1295, and setting out what happens next: infringement notices, product seizures, import interventions, and civil or criminal penalties.
The advertising rule itself is not new. Advertising a prescription-only medicine to the public is prohibited under sections 42DL(10) and 42DLB(7) of the Therapeutic Goods Act 1989. There is a lawful clinical pathway for individual care, and clinics routinely mistake that pathway for permission to market the product. It is not.
Section 133 of the National Law also governs advertising a regulated health service. Restricted representations about serious diseases need TGA permission, and prohibited representations are not available at all. The primary sources are public: the TGA's June 2026 statement on unapproved peptides, the restrictions on advertising prescription medicines to the public, and the AHPRA advertising hub. In 2026, reading these is not optional.
GhostRank is my proprietary 226-point audit. It checks how a page ranks on Google, how it reads to AI search, and where it breaks the advertising rules. Clinics pay $1,500 for this audit on its own. When you hire me, every page runs through it, and you never pay for it.

Five pages for $2,490. Ten pages for $4,390.
Your full site. Ads and articles, if you want them.
The GhostRank Audit is $1,500 and covers up to 20 pages, with a suggested compliant rewrite for every flag it raises. Ongoing SEO is quoted on your scope, six month minimum. No hourly billing, on any of it.
Dear clinic owner,
You built a clinic around treatments patients actively search for. Then you found out you are not allowed to name them.
Peptides sit on top of two rulebooks that were never written with each other in mind. Your growth team wants to use the compound name. The Therapeutic Goods Act says you cannot. So the page goes vague, the enquiries drop, and everyone blames the copy.
Vague is not the only compliant option. You can write a specific, confident page about the consultation itself: who it is for, what it costs, how the doctor decides. That page is legal, and it converts better.
I write to these rules every single day. No delivered work of mine has been flagged by a regulator to date.
So let me take the words off your plate. Every claim checked. Every page written to sell the consult, not the compound.
You built the clinic. Let me handle the words.
Fixed prices. Evidence report. AHPRA and TGA checked before you see a single line.
No, not to the public. Advertising a prescription-only medicine to the public is prohibited under sections 42DL(10) and 42DLB(7) of the Therapeutic Goods Act 1989, and advertising a therapeutic good that is not in the ARTG is separately unlawful. Most peptides are both. You can advertise the consultation instead.
Because they are two different permissions. A practitioner may prescribe an unapproved product for a specific patient, and a pharmacist may compound it. That is a clinical pathway for individual care. It says nothing about advertising to the public, which is prohibited.
Yes. Section 133 of the National Law applies to a person who advertises a regulated health service, not only registered practitioners. The clinic company is caught, and so is whoever controls the advertising. The biggest effect is that patient reviews about clinical care cannot be used in your marketing.
You write about the consultation with real specificity. Who it suits, what happens on the call, what it costs, how the doctor decides, and what happens if treatment is not appropriate. A precise page about the service beats a vague page hinting at a compound.
You can describe the concerns your clinicians consult on. What you cannot do is promise an outcome, or make a restricted representation about a serious disease without TGA permission. The safe pattern is to describe the appointment and the assessment rather than the result.
Tell me about your service and what you need written. I read every brief myself.
Currently taking on new peptide clinic projects
Faster on your phone? WhatsApp me your website link.
Prefer email? amisha@commasandchaos.com